<div>1. Castro C, Gourley M. Diagnosis and treatment of inflammatory
myopathy: issues and management. Therapeutic advances in musculoskeletal
disease. 2012;4(2):111-20.</div><div>2. Whitaker JN. Inflammatory myopathy: a review of etiologic and
pathogenetic factors. Muscle &amp; Nerve: Official Journal of the American
Association of Electrodiagnostic Medicine. 1982;5(8):573-92.</div><div>3. Shamim EA, Rider LG, Miller FW. Update on the genetics of the
idiopathic inflammatory myopathies. Current opinion in rheumatology.
2000;12(6):482-91.</div><div>4. Targoff IN, Miller FW, Medsger Jr TA, Oddis CV. Classification
criteria for the idiopathic inflammatory myopathies. Current opinion in
rheumatology. 1997;9(6):527-35.</div><div>5. Mainetti C, Terziroli Beretta-Piccoli B, Selmi C. Cutaneous
manifestations of dermatomyositis: a comprehensive review. Clinical
reviews in allergy &amp; immunology. 2017;53:337-56.</div><div>6. Gowdie PJ, Allen RC, Kornberg AJ, Akikusa JD. Clinical features and
disease course of patients with juvenile dermatomyositis. International
Journal of Rheumatic Diseases. 2013;16(5):561-7.</div><div>7. Leclair V, Notarnicola A, Vencovsky J, Lundberg IE. Polymyositis:
does it really exist as a distinct clinical subset? Current Opinion in
Rheumatology. 2021;33(6):537-43.</div><div>8. Ioannou Y, Sultan S, Isenberg DA. Myositis overlap syndromes. Current
opinion in Rheumatology. 1999;11(6):468-74.</div><div>9. Nistala K, Wedderburn LR. Update in juvenile myositis. Current
opinion in rheumatology. 2013;25(6):742.</div><div>10. Adler BL, Cristopher-Stine L. Triggers of inflammatory myopathy:
insights into pathogenesis. Discovery medicine. 2018;25(136):75.</div><div>11. Tiniakou E, Mammen AL. Idiopathic inflammatory myopathies and
malignancy: a comprehensive review. Clinical reviews in allergy &amp;
immunology. 2017;52:20-33.</div><div>12. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio
A, et al. Frequency of specific cancer types in dermatomyositis and
polymyositis: a population-based study. Lancet. 2001;357(9250):96-100.</div><div>13. Luu X, Leonard S, Joseph KA. Dermatomyositis presenting as a
paraneoplastic syndrome with resolution of symptoms following surgical
management of underlying breast malignancy. J Surg Case Rep.
2015;2015(7).</div><div>14. Pestronk A, Kos K, Lopate G, Al‐Lozi MT. Brachio‐cervical
inflammatory myopathies: clinical, immune, and myopathologic features.
Arthritis &amp; Rheumatism: Official Journal of the American College of
Rheumatology. 2006;54(5):1687-96.</div><div>15. Fujita J, Tokuda M, Bandoh S, Yang Y, Fukunaga Y, Hojo S, et al.
Primary lung cancer associated with polymyositis/dermatomyositis, with a
review of the literature. Rheumatology international. 2001;20:81-4.</div><div>16. Cherin P, Piette J, Herson S, Bletry O, Wechsler B, Frances C, et
al. Dermatomyositis and ovarian cancer: a report of 7 cases and
literature review. The Journal of Rheumatology. 1993;20(11):1897-9.</div><div>17. Padniewski JJ, Nelson E, Mian I, Laczniak A, Ives S, Nasr R.
Paraneoplastic myopathy in pancreatic cancer: a case report and
literature review. Journal of Community Hospital Internal Medicine
Perspectives. 2021;11(6):847-51.</div><div>18. Narasimhaiah DA, Premkumar JA, Moses V, Chacko G. Carcinoma of gall
bladder presenting as dermatomyositis. Annals of Indian Academy of
Neurology. 2011;14(1):44.</div><div>19. Castro C, Khan Y, Awasum M, Belostocki K, Rosenblum G, Belilos E, et
al. Case report: primary gastric melanoma in a patient with
dermatomyositis. The American journal of the medical sciences.
2008;336(3):282-4.</div><div>20. Buchbinder R, Hill CL. Malignancy in patients with inflammatory
myopathy. Current rheumatology reports. 2002;4(5):415-26.</div>